Biogen, Inc. (BIIB)
191.29
-13.24
(-6.47%)
USD |
NASDAQ |
May 14, 16:00
192.60
+1.31
(+0.68%)
After-Hours: 20:00
Biogen Total Liabilities (Quarterly) : 10.83B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Amgen, Inc. | 83.31B |
| Gilead Sciences, Inc. | 32.85B |
| AbbVie, Inc. | 143.08B |
| Apellis Pharmaceuticals, Inc. | 667.61M |
| Moderna, Inc. | 4.08B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 29.48B |
| Shareholders Equity (Quarterly) | 18.65B |
| Debt to Equity Ratio | 0.3518 |
| Current Ratio | 3.065 |
| Net Debt Paydown Yield | 0.11% |